Trial Shows Benefit in Earlier Use of Zytiga
Friday, March 9, 2012 - 01:10
in Psychology & Sociology
The study of Zytiga from Johnson & Johnson also showed that it could pose a competitive threat to a rival drug, Provenge from Dendreon.